DANAHER CORP. DL-,01/ US2358511028 /
6/19/2024 9:59:16 PM | Chg. -3.650 | Volume | Bid9:59:35 PM | Ask9:59:35 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
236.000EUR | -1.52% | 6,759 Turnover: 1.61 mill. |
235.500Bid Size: 126 | 236.450Ask Size: 126 | 177.52 bill.EUR | - | - |
GlobeNewswire
3/8
Resilinc CEO Honored With a 2024 Pros to Know Lifetime Achievement Award from Supply & Demand Chain ...
GlobeNewswire
2/26
DANAHER ALERT: Bragar Eagel & Squire, P.C. is Investigating Danaher Corporation on Behalf of Long-Te...
GlobeNewswire
1/29
DANAHER ALERT: Bragar Eagel & Squire, P.C. is Investigating Danaher Corporation on Behalf of Long-Te...
GlobeNewswire
12/13/2023
Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase
GlobeNewswire
11/15/2023
Brady Corporation elects Board of Directors and declares regular dividend to shareholders
GlobeNewswire
11/14/2023
Lincoln Electric Appoints J. Ashley Hall as Senior Vice President, Global Procurement
GlobeNewswire
11/1/2023
Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaign
GlobeNewswire
10/16/2023
Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher...
GlobeNewswire
10/12/2023
Coave Therapeutics appoints Leading World Experts to newly formed Scientific Advisory Board dedicate...
GlobeNewswire
10/2/2023
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
GlobeNewswire
10/1/2023
Lifshitz Law PLLC Announces Investigations of Integra LifeSciences Holdings Corporation (NASDAQ: IAR...